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ABSTRACT: Isobaric peptide termini labeling (IPTL) is an
attractive protein quantification method because it provides more
accurate and reliable quantification information than traditional
isobaric labeling methods (e.g., TMT and iTRAQ) by making use
of the entire fragment-ion series instead of only a single reporter
ion. The multiplexing capacity of published IPTL implementations
is, however, limited to three. Here, we present a selective maleylation-directed isobaric peptide termini labeling (SMD-IPTL)
approach for quantitative proteomics of LysC protein digestion. SMD-IPTL extends the multiplexing capacity to 4-plex with the
potential for higher levels of multiplexing using commercially available 13C/15N labeled amino acids. SMD-IPTL is achieved in a
one-pot reaction in three consecutive steps: (1) selective maleylation at the N-terminus; (2) labeling at the ε-NH2 group of the C-
terminal Lys with isotopically labeled acetyl-alanine; (3) thiol Michael addition of an isotopically labeled acetyl-cysteine at the
maleylated N-terminus. The isobarically labeled peptides are fragmented into sets of b- and y-ion clusters upon LC-MS/MS, which
convey not only sequence information but also quantitative information for every labeling channel and avoid the issue of ratio
distortion observed with reporter-ion-based approaches. We demonstrate the SMD-IPTL approach with a 4-plex labeled sample of
bovine serum albumin (BSA) and yeast lysates mixed at different ratios. With the use of SMD-IPTL for labeling and a narrow
precursor isolation window of 0.8 Th with an offset of −0.2 Th, accurate ratios were measured across a 10-fold mixing range of BSA
in a background of yeast proteome. With the yeast proteins mixed at ratios of 1:5:1:5, BSA was detected at ratios of
0.94:2.46:4.70:9.92 when spiked at 1:2:5:10 ratios with an average standard deviation of peptide ratios of 0.34.
Proteome quantification gives information on the relativeamounts of a large number of proteins between samples.1−3
The existing mass-spectrometry-based proteome-wide quanti-
tative methods can be classified into label-free proteomics4,5 and
label-based proteomics.6−8 Even though advanced data-
acquisition schemes and algorithms have been developed for
label-free proteomics, the limited throughput and signal
variation due to, among others, variable sample loss during
workup and changing ionization efficiency between injections
argue in favor of multiplexed, label-based proteomics. Multi-
plexed quantification approaches (e.g., ICAT,6,9,10 SILAC,11−13
iTRAQ,7,14 TMT,8,15 and IPTL16−21) exploit different combi-
nations of heavy and light isotopes to differentially label
peptides, which enables simultaneous sample workup and LC-
MS/MS analysis of multiple samples in a single experiment. The
commonly used isotopes are 13C, 15N, 18O, and 2H, with 2H
being less popular because of the potential risk of altering the
peptide retention time.22−25
The existing multiplexing strategies can also be classified into
two categories, MS1 quantification and MS2 quantification, on
the basis of the stage at which peptides are quantified.26 ForMS1
quantification, also called isotopic quantification, such as
SILAC12 and ICAT,6 the same peptide from different samples
will be labeled with different isotopic tags, which results in the
same peptide showing multiple precursor ions at the MS1 level.
Relative quantification is achieved by comparing the intensities
or peak areas of the precursor ions at the MS1 level. Therefore,
any isotopic quantification method will at least double the
complexity of the MS1 spectrum, which further aggravates the
already challenging issue of a limited sampling capacity of
precursor ions for MS/MS fragmentation across a chromato-
graphic peak. In contrast, the MS2 quantification methods use
isobarically labeled peptides, so the same peptide originating
from different samples will have the same mass. After
fragmentation, the isobarically labeled peptide will release a
unique reporter ion (TMT and iTRAQ) or peptide fragment
ions (IPTL), which can be used to reveal the quantification
information. TheMS2 quantificationmethods not only allow for
the straightforward quantification of multiple samples in a single
MS2 spectrum but also further reduce the required instrument
time. The most widely used isobaric quantification methods are
those using reporter-ion tags (TMT and iTRAQ) because of the
multiplex capacity and well-developed data-processing software.
However, reporter-ion-based quantificationmethods suffer from
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ratio distortion,26−31 which is particularly serious in complex
samples, arising from the cofragmentation of multiple peptides
passing the precursor-ion selection window. These peptides
release identical reporter ions that are indistinguishable in MS2.
To correct for the ratio distortion, several methods have been
proposed, such as additional gas-phase purification31 and
MultiNotch MS3.27 An alternative isobaric method that gives
rise to multiple quantification ions per peptide and is therefore
less affected by the cofragmentation problem is isobaric peptide
termini labeling (IPTL). IPTL was first reported in 2009 by
Koehler et al.,16 but the approach is not as extensively used as
TMT and iTRAQ, presumably because of the limited multi-
plexing capacity, especially when avoiding deuterium labeling.
The initially reported IPTL method showed relative
quantification of two samples of LysC digested proteins,
where the peptides were crosswise-modified at the C- and N-
terminus with a pair of complementary isotopic tags, resulting in
isobarically labeled peptides that were fragmented into product-
ion clusters. The peptide and protein ratios can be inferred by
comparing the intensities of the individual y- and b-series
fragment ions. Even in the case of cofragmentation of two or
more peptides, fragment ions can usually be correctly attributed.
IPTL potentially permits more accurate and reliable quantifica-
tion with multiple quantification data points per spectrum, for
each y- and b-ion, and suffers less from cofragmentation.
Consequently, a number of optimized methods and applications
have been reported in the past 10 years, such as selective
succinylation17 and dimethylation19,32−35 based IPTL (triplex-
IPTL19 and triplex-QITL21), SILAC34,35 or proteolytic 18O
labeling33,36 combined with IPTL (IVTAL,18 G-IVTL,34
QITL,33 and diDO-IPTL36), and pseudoisobaric dimethyl
labeling20,37−40 (pIDL,37 PITL,38 SWATH-pseudo-IPTL,20
and MdFDIA41). Most of the methods are for duplex labeling
or triplex at most, which means that the multiplexing capacity of
IPTL is still far less than that of TMT, which has been extended
to 16 labeling channels in a single LC-MS/MS run.42 Recently,
Liu et al.40 reported the pseudoisobaric dimethyl labeling (m-
pIDL)method, which increased the multiplex capacity to 6-plex.
m-pIDL does not suffer from cofragmentation while relying on a
wide isolation window of 10 Th. A potential limitation is the
utilization of deuterium in the isotopic tags, which carries the
risk of changing the retention time of labeled peptides.
To improve the IPTL multiplex capacity with nondeuterium
tags, we propose the selective maleylation-directed isobaric
peptide termini labeling (SMD-IPTL) method, which is based
on selective maleylation at the N-termini of LysC digested
peptides. The performance of SMD-IPTL was assessed at the 4-
plex level by spiking different amounts of bovine serum albumin
(BSA) into a yeast proteome background. SMD-IPTL can be
extended to the 7-plex level using commercially available 13C- or
15N-labeled cysteine and alanine.
■ EXPERIMENTAL SECTION
Details of the used chemicals and materials, the synthesis of
isotopically labeled acetyl-cysteine and the acetyl-alanine p-
nitrophenol ester, LC purification, LysC digestion, LC/MS/MS
analysis, and database searching and quantification can be found
in the Supporting Information.
Optimization of Selective Maleylation at the Peptide
N-Terminus. Solutions of different pH values (7.0, 6.5, 6.0, 5.5,
and 5.0) were prepared with 100 mM sodium acetate and acetic
acid.17 Subsequently, the peptide WLYRAK was dissolved in
solutions of different pH values (7.0, 6.5, 6.0, 5.5, and 5.0) to a
concentration of 10 μM. Then 4 μg/μL maleic anhydride was
freshly prepared in acetonitrile and 2 μL was added to 100 μL of
each WLYRAK solution. The reaction tube was shaken at room
temperature for 30 min. The reaction was tracked with LC-MS.
Maleylation on LysC peptides was further optimized by infusing
50 μg/μL maleic anhydride with a syringe pump at a flow rate of
0.4 μL/min into 25 μg of LysC peptides dissolved in 1 mL of
sodium acetate−acetic acid solution at pH 5.5 for 1 h.
2-Plex Labeling of Maleylated WLYRAK. Maleylated
peptide solution (100 μL) was dried in a vacuum concentrator,
followed by the addition of 100 μL of 50 mM sodium
tetraborate, and the pH was adjusted to 9 with 500 mM
NaOH. Then 100 mM 13C1-acetyl-alanine p-nitrophenol ester
(13C1-Ac-Ala-PNP) containing one
13C label in the acetyl group
or acetyl-alanine-p-nitrophenol ester (Ac-Ala-PNP), which
contains no 13C label, was prepared in dimethyl formamide.
Subsequently, 2 μL of p-nitrophenol ester was added to the
maleylated peptide solution and incubated for 1 h at room
temperature. To ensure complete labeling, 2 μL of p-nitrophenol
ester was added again and incubated for 30minmore. Afterward,
the pH of acetyl-alanine labeled solutions was adjusted to 9.
Subsequently, 5 μL of 400 mM 13C1-acetyl-cysteine (
13C1-Ac-
Cys-OH), which contains one 13C label in the acetyl group, was
added to the Ac-Ala-PNP labeled solution. Conversely, 5 μL of
400 mM acetyl-cysteine (Ac-Cys-OH) was added to the 13C1-
Ac-Ala-PNP labeled solution. The reaction solutions were
bubbled with argon for 5 min and incubated overnight at 55 °C.
Finally, potentially formed esters at the hydroxyl groups of Ser,
Thr, or Tyr and excess PNP ester were hydrolyzed by treatment
with 5% hydroxylamine43 for 5 min at 55 °C prior to desalting
the samples by SPE using the STAGE (STop And Go
Extraction) TIPS Desalting Procedure44 followed by LC-MS
analysis.
4-Plex Isobaric Labeling of LysC Peptides. Maleylated
LysC peptides (400 μL) of BSA or yeast protein was mixed with
50 μL of 100mM sodium tetraborate and the pHwas adjusted to
9 with 5 M NaOH. The solution was split into four tubes for




Ala-PNP was respectively added to the four tubes of maleylated
LysC peptide solution and incubated for 1 h at room
temperature. To ensure complete labeling, 2 μL of p-nitrophenol
ester was added again and incubated for 30minmore. Afterward,
the pH of acetyl-alanine-p-nitrophenol ester labeled solutions
was adjusted to 9. Ten microliters of 400 mM 13C3-Ac-Cys-OH
was added to the Ac-Ala-PNP labeled solution, 10 μL of 400mM
13C2-Ac-Cys-OH was added to the
13C1-Ac-Ala-PNP labeled
solution, 10 μL of 400 mM 13C1-Ac-Cys-OH was added to the
13C2-Ac-Ala-PNP labeled solution, and 10 μL of 400 mM Ac-
Cys-OH was added to the 13C3-Ac-Ala-PNP labeled solution.
The reaction solutions were bubbled with argon for 5 min and
incubated overnight at 55 °C. Finally, potentially formed esters
at the hydroxyl groups of Ser, Thr, or Tyr and excess PNP ester
were hydrolyzed by treatment with 5% hydroxylamine43 for 5
min at 55 °C prior to desalting the samples by SPE using the
STAGE (STop And Go Extraction) TIPS Desalting Proce-
dure44 followed by LC-MS analysis.
■ RESULTS AND DISCUSSION
Improving the Multiplexing Capacity of IPTL. SMD-
IPTL not only retains all of the merits of IPTL16,17,19 but also
improves it by (I) increasing the multiplex capacity to 4-plex or
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Figure 1. Scheme of SMD-IPTL. (A) Labeling steps of SMD-IPTL. (B) Seven possible combinations of isotopically labeled acetyl-cysteine and acetyl-
alanine. The atom marked with “*” denotes 13C or 15N. (C) LC-MS/MS process for a mixture of 7-plex labeled samples.
Figure 2.Optimization of maleylation and isobaric labeling of peptide WLYRAK. (A) Maleylation in various pH buffers. XICs ofm/z 418.74, 467.74,
and 516.74 were combined for all pH values. Peak a in the extracted ion chromatograms is the unmodified peptide; peak b is the peptide selectively
maleylated on the α-NH2 group; peak c is the double-maleylated peptide on both α-NH2 and ε-NH2 groups. (B) One-pot isobaric labeling reaction
steps. Extracted Ion Chromatograms (XICs) of m/z 467.74, 524.27, and 605.78 were combined for all steps. Peak b is the single-maleylated peptide
(Ma-WLYRAK); peak d is the peptide after labeling with acetyl-alanine at the ε-NH2 group (Ma-WLYRAK-Ac-Ala); peak e is the peptide after thiol
Michael addition of acetyl-cysteine (Ac-Cys-Ma-WLYRAK-Ac-Ala). Mass spectra are shown to the right of the chromatograms. (C) Enlarged view of
the y3-ion in the MS2 spectrum for different mixing ratios of f,
13C1-Ac-Cys-WLYRAK-Ac-Ala, and g, Ac-Cys-WLYRAK-Ac-Ala-
13C1. (D) MS2
spectrum of 1:1 mixed 13C1-Ac-Cys-WLYRAK-Ac-Ala and Ac-Cys-WLYRAK-Ac-Ala-
13C1. The peak marked with “*” is the precursor ion having lost
the Ac-Ala group.
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more with readily available isotopically labeled amino acids and
(II) utilizing non-deuterium labeled tags to ensure that
isobarically labeled peptides have the same retention time.
Inspired by selective succinylation17 and thiol Michael
addition on maleic derivatives,45 we assumed that maleic
anhydride has comparable selective reactivity for the peptide N-
terminus as succinic anhydride. The introduced maleic
derivatives at the N-terminus can be used for further
modification. We decided to use readily available 13C and 15N
labeled amino acids as tag building blocks. As shown in Figure
1A, the isobaric labeling can be achieved in a one-pot reaction
with three consecutive steps: (1) selective maleylation at the N-
terminus; (2) labeling with acetyl-alanine-p-nitrophenol ester at
the ε-NH2 group of the C-terminal Lys; (3) thiol Michael
addition at the double bond of the newly maleylated N-
terminus. As a result, the LysC peptides will be isobarically and
differentially labeled at the N- and C-terminus with a
complementary pair of isotopically labeled acetyl-cysteine and
acetyl-alanine, respectively.With commercially available isotopi-
cally labeled cysteine and alanine, seven isobaric combinations
can potentially be made, without the need for deuterium labels,
as shown in Figure 1B. The isobarically labeled peptides derived
from different samples are mixed prior to LC-MS/MS analysis
(Figure 1C) and have identical retention times and masses. The
MS2 peak intensities of y- and b-ion series fragments for each
labeling channel are extracted and their intensity ratios represent
the difference in the amount of the peptides in each sample in
the mixture, as shown in the inset in Figure 1C.
Optimization of the Selective Maleylation Reaction.
Crosswise labeling of the N-terminal α-NH2 group and Lys ε-
NH2 group with a pair of complementary tags is the prerequisite
for IPTL. The challenge of IPTL therefore lies in the selective
labeling of these two forms of the −NH2 group with readily
available tags. Both selective succinylation17 and selective
dimethylation32 have been used in IPTL, exploiting the pKa
difference between α- and ε-amino groups to selectively label the
α-NH2 group at a specific pH. Maleic anhydride has a similar
structure and reactivity as succinic anhydride, but the carbon
double bond in the maleic anhydride permits further
derivatization after maleylation, which can be used to insert an
isotopic tag at the peptide N-terminus.45 We used the peptide
WLYRAK to investigate the reactivity and selectivity of
maleylation at various pH values (pH 7.0, 6.5, 6.0, 5.5, and
5.0) and in water. As shown in Figure 2A, selectivity of
maleylation for the α-NH2 group increases as the pH decreases.
However, the reaction is not complete at pH 5.0, so pH 5.5
presents the best compromise between overall reaction yield and
selectivity with an overall yield of more than 90% and a double
maleylation of 5−8% (see Figure S5 for theMS2 spectrum of the
N-maleylated peptideMa-WLYRAK). The selective maleylation
reaction was further optimized by infusion of 50 μg/μL maleic
anhydride with a syringe pump at a flow rate of 0.4 μL/min into
the peptide solution at pH 5.5. As shown in Figure S6, double
maleylation was further reduced to less than 2%. The amount of
double-maleylated peptide did not increase when the infusion
time was prolonged. On the basis of these results, sodium acetate
at pH 5.5 and slow infusion of maleic anhydride with a syringe
pump at 0.4 μL/min were used for optimal selective maleylation.
One-Pot Isobaric Labeling of Peptide WLYRAK. After
selective maleylation at the α-NH2 group,
13C1-Ac-Ala-PNP or
Ac-Ala-PNP was used to react with the ε-NH2 group of the C-
terminal Lys at pH 9. As shown in Figure 2B, Ma-WLYRAK can
be completely converted to Ma-WLYRAK-Ac-Ala-13C1 or Ma-
WLYRAK-Ac-Ala. Subsequently, after the pH was adjusted to 9,
the complementary isotopic form of acetyl-cysteine was
incorporated to generate 13C1-Ac-Cys-WLYRAK-Ac-Ala and
Ac-Cys-WLYRAK-Ac-Ala-13C1. Although the newly inserted N-
terminal maleyl group is less reactive to thiol than maleimide,
Figure 3. Reducing interference of the endogenous 13C contribution to the fragment ions by narrowing the width of the precursor isolation window
(IW). Peptides are from the 4-plex labeled LysC digested BSA. (A) y5-ion of
13C3-Ac-Cys-Ma-SEIAHRFK-Ac-Ala; (B) y5-ion of
13C2-Ac-Cys-Ma-
SEIAHRFK-Ac-Ala-13C1; (C) y5-ion of
13C1-Ac-Cys-Ma-SEIAHRFK-Ac-Ala-
13C2; (D) y5-ion of Ac-Cys-Ma-SEIAHRFK-Ac-Ala-
13C3; (E) IW of 2 Th
to select the precursor ion of isobarically labeled SEIAHRFKmixed at a ratio of 1:1:1:1; (F) y5-ion of isobarically labeled SEIAHRFKmixed at a ratio of
1:1:1:1 and fragmented with an IW of 2 Th; (G) IWof 0.8 Th with a−0.2 Th offset to select the precursor ion of isobarically labeled SEIAHRFKmixed
at a ratio of 1:1:1:1; (H) y5-ion of isobarically labeled SEIAHRFKmixed at a ratio of 1:1:1:1 and fragmented with an IWof 0.8 Thwith a−0.2 Th offset;
(I) IW of 0.8 Th with a −0.2 Th offset to select the precursor ion of isobarically labeled VPQVSTPTLVEVSRSLGK mixed at a ratio of 1:1:1:1; (J),
(K), and (L), respectively show the b1-, y6-, and y15-ions of isobarically labeled VPQVSTPTLVEVSRSLGKmixed at a ratio of 1:1:1:1 and fragmented
with an IW of 0.8 Th with a −0.2 Th offset.
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Tian et al. demonstrated that the maleyl group can efficiently
react with cysteine and mercaptoethanol.45 However, we found
that the thiol Michael addition was slow, taking more than 30 h
to complete. After screening various additives, including
triethylamine,46 hexylamine, proline,47 dimethylphenylphos-
phine,46 and sodium tetraborate,48 we found that sodium
tetraborate enables full labeling of the N-terminal maleyl group
in 15 h (Figure S7).
To demonstrate the feasibility of SMD-IPTL, isobarically
labeled 13C1-Ac-Cys-WLYRAK-Ac-Ala and Ac-Cys-WLYRAK-
Ac-Ala-13C1 were mixed at various ratios (1:1, 1:5, 1:10, 1:20,
5:1, 10:1, and 20:1) followed by LC-MS/MS analysis. As shown
in Figure 2D, the fragment ions cover the entire b-ion series and
several y-ions, which means that fragmentation of the peptide
backbone works well after tags were inserted on both termini.
Notably, every y- and b-ion appeared as a peak pair in the
spectrum, as shown in Figure 2C (enlarged view of the y3-ion for
different mixing ratios). The relative intensity of the light and
heavy peaks is consistent with the corresponding mixing ratio.
Figure S8 shows the correlation between experimental and
theoretical ratios over the tested mixing ratios, which indicates
that accurate quantification can be achieved over a 20-fold
dynamic range for peptide WLYRAK.
Reducing Isotope Interference of Fragment Ions by
Using a Narrow Precursor Isolation Window. In the MS2
spectra of IPTL, every labeling channel has a set of unique
fragment ions, which represent the main advantage of IPTL by
providing more accurate and reliable quantification information
because the entire fragment-ion series contains ratio information
instead of only the reporter ion in the TMT and iTRAQ
reporter-ion-based approaches. Figure 3A−D shows the y5-ion
of isobarically labeled SEIAHRFK (a BSA-derived peptide after
LysC digestion) from four labeling channels with an interval of 1
Da between the channels. However, with a precursor isolation
window (IW) of 2 Th, which is the default setting in data-
dependent acquisition (DDA) proteomics on Orbitrap mass
spectrometers, deducing quantification ratios from intensities of
fragment ions is complicated because of the interference of the
natural 13C contribution to the isotopologue pattern of the
fragment ions.28 As shown in Figure 3E, setting the isolation
window to 2 Th in the LC-MS/MS analysis of a 1:1:1:1 mixed
BSA sample resulted in an MS2 spectrum (Figure 3F) in which
the ratio of the y5-ions did not correspond to the expected
1:1:1:1 ratio because there is a small additional 13C peak next to
the four major peaks. The use of a narrow precursor isolation
window29,49 has been reported to reduce the 13C contribution to
the fragment ions. As shown in Figure 3G, when the isolation
window was set at 0.8 Th with −0.2 Th offset to specifically
select the monoisotopic peak, the ratio between the y5-ions
perfectly matched the expected 1:1:1:1 ratio (Figure 3H).
However, on the Q Exactive plus mass spectrometer, the
precursor-ion selection automatically shifts the isolation window
to the center on the highest intensity peak, rather than the
monoisotopic peak, which means that for peptides above ∼2
kDa multiple isotopologues are cofragmented. This means that,
for the labeled peptide VPQVSTPTLVEVSRSLGK (2273.14
Da), even with a narrow isolation window of 0.8 Th and an offset
of −0.2 Th (Figure 3I), the 13C contribution still affected the
MS2 spectrum. As shown in Figure 3J−L, the 13C contribution
increases with fragment-ion mass. Therefore, for the MS2
spectra derived from peptides where the isolation window is
centered on the first 13C isotopologue, only the small fragment
ions y2, b1, and b2 were used for data processing. The y1-ion was
never used for quantification because all peptides in LysC
Figure 4.Normalized ratios distribution of 4-plex labeled BSAmixed at various ratios. (A) Normalized ratios of all assigned fragment ions from 1:1:1:1
mixed 4-plex labeled BSA; (B) normalized ratios of identified peptides from 1:1:1:1 mixed 4-plex labeled BSA; (C) normalized ratios of identified
peptides from 1:5:1:5 mixed 4-plex labeled BSA; (D) normalized ratios of identified peptides from 1:2:5:10 mixed 4-plex labeled BSA.
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digestion have the same y1-ion, which may distort ratios by
peptide cofragmentation similar to reporter-ion-based ap-
proaches.40 Fragment ions other than the main b- and y-ion
series, such as those havingH2O andNH3 loss, were also ignored
because of the increased likelihood of convolution between
them.
After preselection of the fragment ions suitable for
quantification, the next step is to calculate the ratios at the
spectrum, peptide, and protein levels sequentially. As shown in
Figure 4A, the log2-normalized ratio has a better convergence to
zero as the intensity of fragment ions increases, which means
that more intense fragments are more reliable and should
contribute more to the calculated ratio. Consequently, the ratio
at the spectrum level was calculated as the normalized ratio of
the sum of all fragment-ion intensities from the same labeling
channel (Figures S3 and S4). The same trend of intensities is
apparent at the peptide level (Figure 4B). Thus, the ratio at the
peptide level was calculated by using the spectra with the three
highest total peak intensities and the ratio at the protein level
was calculated by using the peptides with the three highest total
peak intensities. According to this calculation, on the basis of
medians of the log2-normalizedmeasured ratios, the 1:5:1:5 and
1:2:5:10 mixed 4-plex labeled BSA ratios were determined to be
1.10:5.28:1.05:4.50 and 1.06:2.60:4.63:9.51 at the peptide level,
as shown in parts (C) and (D), respectively, of Figure 4.
4-Plex Labeling of LysC Peptides of the Yeast
Proteome. To evaluate the efficiency and reproducibility of
SMD-IPTL labeling reactions and the quantification accuracy
on a complex sample, 4-plex labeling was performed on the LysC
peptides from a yeast proteome. Three replicate maleylation
reactions were performed and the maleylation yield of each
peptide was determined as the percentage of intensity of the N-
terminal maleylated form to the total intensity of all possible
forms including unmodified, N-terminal maleylated, C-terminal
maleylated, and both N- and C-terminal maleylated peptide. As
shown in Table 1 and Figure S9, around 95% of the peptides had
a labeling yield higher than 90% and the average coefficient of
variation (CV) of three replicates was 14.0%. The efficiency and
reproducibility of subsequent labeling steps of the four channels
with four pairs of complementary acetyl-cysteine and acetyl-
alanine-p-nitrophenol ester can be found in Figure S10. More
than 98% of identified peptides had a total yield above 98% and
an average CV of 1.3%.
To investigate the quantification accuracy of SMD-IPTL in a
complex sample, the 4-plex labeled LysC yeast peptides were
mixed at a ratio of 1:1:1:1 and analyzed with an isolation window
of 0.8 Th and an offset of −0.2 Th. As shown in Figure 5A, the
log2-normalized ratios are mainly distributed over the range
from −0.4 to 0.4. The medians of log2-normalized ratios of the
four labeling channels are 0.03, 0.03, −0.06, and −0.03,
respectively (Figure 5A). On the protein level (337 proteins
were identified), 97.0% of the proteins were quantified within a
2-fold range and 91.7% of proteins were quantified within a 1.5-
fold range.
Quantifying BSA in a Background of Yeast Proteins.
To investigate the dynamic range of SMD-IPTL in a complex
background, a BSA-yeast proteome sample was prepared. 4-Plex
labeled LysC peptides of BSA at a ratio of 1:2:5:10 and 4-plex
labeled LysC peptides of yeast proteins at the ratio of 1:5:1:5
were mixed separately. The yeast peptides were then mixed with
peptides of BSA, according to the scheme shown in Figure 5B.
The mixed BSA-yeast sample was analyzed with an isolation
window of 0.8 Th and an offset of −0.2 Th. To assess the
quantification of the yeast proteins, as shown in Figure 5B, the
medians of log2-normalized protein ratios of the four labeling
channels were determined as −0.01, 2.37, 0.15, and 2.29,
respectively, close to the theoretical medians of 0, 2.32, 0, and
2.32. In the channels of Ac-Cys-Ma-peptides-Ac-Ala-13C3 and
13C2−Ac-Cys-Ma-peptides-Ac-Ala-13C1, 4 times lower amounts
of yeast peptides were mixed than in the other two channels, and
the quantified protein ratios therefore had a larger variation. The
1:5:1:5 mixed channels of yeast had an average standard
deviation of all log2 ratios of 0.40. For 4-plex labeled BSA, the
log2-normalized protein ratios were −0.09:1.30:2.23:3.31,
which is c lose to the log2-theoret ical rat ios of
0.00:1.00:2.32:3.32.
Although SMD-IPTL exhibits good quantification capability
across a 10-fold dynamic range, there is still room for
improvement with respect to peptide identification, which is a
prerequisite for calculating theoretical fragment ions as required
for relative peptide quantification. In the MS2 spectra of SMD-
IPTL, the number of fragment ions is multiplied by the number
of labeling channels, which provides more accurate quantifica-
tion information. However, this also makes identification more
challenging because of the more complex MS2 spectra, which
are not properly handled by existing protein identification
software50,51 because unmatched fragment-ion peaks reduce the
peptide score. The development of identification algorithms
capable of handling IPTL data would further improve the
identification of peptides in SMD-IPTL samples and hence the
number of quantified proteins. In addition, data acquisition
software that is capable of specifically selecting the mono-
isotopic peak for all peptides in combination with a narrow
precursor isolation window would further improve the
quantification accuracy of SMD-IPTL. We observed that
peptide ionization efficiency decreased slightly after isobaric
labeling, which might be caused by modification of the amino
groups of the peptides. Finally, the multiplexing capacity of
SMD-IPTL can be further improved by extending the range of
isotopic forms of Cys and Ala and the use of mass spectrometers
with sufficient resolution to distinguish 13C and 15N isotopes in
fragment ions.52
■ CONCLUSIONS
SMD-IPTL not only retains all the advantages of IPTL
approaches but also improves the multiplexing capacity to at
least 4-plex labeling with available non-deuterium isotopically
labeled amino acids. SMD-IPTL is readily expandable to 7-
plexing following the same strategy. Isobaric labeling of peptides
is achieved in a one-pot reaction comprising three steps. We
applied a precursor-ion isolation window of 0.8 Th with an offset
of −0.2 Th during data acquisition, which significantly helped
deducing protein ratios from intensities of fragment ions.
Finally, the proteome quantification capability of SMD-IPTL
was demonstrated with the 4-plex labeling of a yeast proteome
Table 1. Efficiency Evaluation of Three Replicates of












replicate 1 2175 95 39 21 72 14.0%
replicate 2 2056 82 53 21 69 13.1%
replicate 3 2083 90 33 16 84 14.8%
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sample spiked with BSA over a 10-fold dynamic range. Further
improvements in data acquisition and data analysis software are
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■ NOTE ADDED AFTER ASAP PUBLICATION
After this paper was published ASAP on May 12, 2020, a
correction was made to Figure 3 (peaks were missing in panel I).
The corrected version was reposted May 13, 2020.
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